San Luis Wealth Advisors’s AbbVie ABBV Stock Holding History

San Luis Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,362	Closed	-$234K	–	144
2024 Q2	$234K	Sell	1,362 -56	-4%	-$9.28K	0.06%	120
2024 Q1	$258K	Sell	1,418 -100	-7%	-$17.2K	0.14%	41
2023 Q4	$235K	Buy	1,518 +56	+4%	+$8.16K	0.1%	52
2023 Q3	$218K	Buy	+1,462	New	+$215K	0.1%	65
2023 Q2	–	Sell	-1,457	Closed	-$232K	–	160
2023 Q1	$232K	Sell	1,457 -22	-1%	-$3.36K	0.09%	148
2022 Q4	$239K	Sell	1,479 -160	-10%	-$24.5K	0.22%	65
2022 Q3	$220K	Buy	1,639 +116	+8%	+$16.6K	0.23%	72
2022 Q2	$233K	Sell	1,523 -8	-0.5%	-$1.22K	0.27%	54
2022 Q1	$207K	Hold	1,531	–	–	0.1%	146
2021 Q4	$207K	Buy	+1,531	New	+$181K	0.21%	84
2020 Q4	$601K	Buy	+5,605	New	+$539K	0.39%	67

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

San Luis Wealth Advisors's ABBV Position: Q3 2024 in Review

San Luis Wealth Advisors sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 1,362 shares — an estimated $234K sold.

San Luis Wealth Advisors first reported a position in ABBV in Q4 2020 and held it in 11 quarters. The position peaked at $601K in Q4 2020. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

San Luis Wealth Advisors reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
San Luis Wealth Advisors sold 1,362 AbbVie shares in Q3 2024, an estimated $234K.
San Luis Wealth Advisors first reported a position in AbbVie in Q4 2020 and held it in 11 quarters.
San Luis Wealth Advisors's AbbVie position peaked at $601K in Q4 2020.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on San Luis Wealth Advisors's 13F filing for Q3 2024, filed 9 Oct 2024.